Visualizing Interferon-beta Induction In Vivo
Visualizing Interferon-beta Induction In Vivo
批准号:
7532495
负责人:
Joan E. Durbin
金额:
$18.0万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-23 至 2010-04-30
关键词:
AffectAllergicAnimal ModelAnimalsAntigen PresentationAntigensAntiviral AgentsAntiviral ResponseAreaAttenuatedCell LineCell MaturationCellsChildChildhoodClinicalCytokine SignalingDendritic CellsDiseaseEffectivenessElderlyEpithelialFamilyGene Expression RegulationGenerationsGenesHost Defense MechanismImmune responseImmunityImmunizationIn VitroIndividualInfantInfectionInfluenzaInfluenza A virusInterferon Type IInterferon-betaInterferonsLaboratoriesLeadLifeLigand BindingLinkLiteratureLymphocyteLymphocyte ActivationMediatingMemoryMusNoseParamyxoviridaePersonal SatisfactionPhasePneumovirusProcessProductionPublic HealthReagentRelative (related person)ReporterReportingResolutionRespiratory Syncytial Virus VaccinesRespiratory Tract InfectionsRespiratory syncytial virusRespiratory syncytial virus RSV proteinsRoleSerumSourceT-LymphocyteTechnologyTimeTransgenic MiceTropismUp-RegulationVaccinatedVertebratesViralVirulenceVirusVirus DiseasesVirus-Cell Membrane Interactioncell typecytokineimmunogenicimmunogenicityin vivointerestmenpathogenpromoterreceptorred fluorescent proteinrespiratoryrespiratory infection virusrespiratory virusresponsevirologyvirus development
中文摘要
描述(由申请人提供):脊椎动物的病毒感染触发多种宿主防御机制,I型干扰素(ifn)是其中最早的一类。I型(或1型和2型)ifn以其抗病毒功能而闻名。所有细胞类型的病毒感染均可诱导IFN-1/2合成。当邻近细胞暴露于分泌的IFN-1/2时,这些配体与IFN-1/2受体的结合导致许多干扰素刺激基因的转录上调,这些基因介导抗病毒状态。这种对病毒入侵的早期先天免疫反应对于限制病毒的复制和传播非常重要。但是,虽然I型IFN反应可以包含病毒感染,但需要抗原特异性T细胞反应来解决。最近在IFN基因调控和功能领域的进展使人们认识到,除了它们的抗病毒作用外,IFN-1/2还在促进对病毒感染的有效和适当的适应性免疫反应中发挥作用。由感染细胞和浆细胞样树突状细胞分泌的IFN-2和IFN-1也能促进抗原呈递、淋巴细胞活化和淋巴细胞存活。由于I型ifn在抗病毒防御中具有如此重要的作用,因此所有研究的病毒都找到了抑制IFN-1/2产生和/或作用的方法也就不足为奇了。这些机制因病原体而异,其有效性可影响病毒的毒力、慢性性和再感染能力。我们的实验室对不同的呼吸道病毒如何在体内诱导I型ifn,以及这些细胞因子的产生如何影响病毒特异性淋巴细胞反应的发展感兴趣。如果我们能够在活动性感染期间追踪干扰素产生的来源和时间,我们研究这些动态过程的能力将显著增强。本应用程序描述了我们的计划,以获得携带由I型IFN启动子驱动的绿色或红色荧光蛋白基因的指示小鼠。这些试剂将使病毒学家能够在体内和体外研究许多不同病毒激活和/或抑制I型IFN产生的能力。病毒感染触发多种宿主防御机制,被称为I型干扰素(ifn)的细胞因子是其中最早的一种。这种对病毒入侵的早期先天免疫反应对限制病毒复制和传播很重要。由于I型IFN在抗病毒防御中具有如此重要的作用,因此所有被研究的病毒都找到了抑制IFN产生或作用的方法也就不足为奇了。本申请描述了我们获得指示细胞系和转基因小鼠的计划,当IFN基因被激活时,它们将发出荧光。这些试剂将使病毒学家能够在体内和体外研究许多不同病毒激活和/或抑制I型IFN产生的能力。
英文摘要
DESCRIPTION (provided by applicant): Virus infection of vertebrates triggers multiple host defense mechanisms, and type I interferons (IFNs) are among the earliest of these. Type I (or 1 and 2) IFNs are best known for their antiviral functions. IFN-1/2 synthesis is induced by virus infection of all cell types. When neighboring cells are exposed to secreted IFN-1/2, the binding of these ligands to the IFN-1/2 receptor leads to the transcriptional upregulation of the many interferon-stimulated genes which mediate the anti-viral state. This very early innate immune response to viral invasion is very important for limiting viral replication and spread. But while the type I IFN response can contain a virus infection, an antigen- specific T cell response is needed for resolution. Recent progress in the area of IFN gene regulation and function has led to the realization that, in addition to their antiviral effects, IFN-1/2 also have a role in promoting an effective and appropriate adaptive immune response to viral infection. IFN-2 and IFN-1 secreted from infected cells and plasmacytoid dendritic cells can also promote antigen presentation, lymphocyte activation, and lymphocyte survival. As type I IFNs have such an important role in anti-viral defense, it is not surprising that all viruses studied have found ways of inhibiting IFN-1/2 production and or action. These mechanisms vary among pathogens, and their effectiveness can influence viral virulence, chronicity, and ability to reinfect. Our laboratory is interested in how different respiratory viruses induce type I IFNs in vivo, and how production of these cytokines affects the development of virus specific lymphocyte responses. Our ability to study these dynamic processes would be markedly enhanced if we were able to trace the source and timing of IFN production during an active infection. This application describes our plans to derive indicator mice carrying a gene for green or red fluorescent protein that is driven by a type I IFN promoter. These reagents will allow virologists to study the ability of many different viruses to activate and/or suppress type I IFN production in vivo and in vitro. PUBLIC HEALTH RELEVANCE Virus infection triggers multiple host defense mechanisms, and the cytokines called type I interferons (IFNs) are among the earliest of these. This very early innate immune response to viral invasion is important for limiting viral replication and spread. As type I IFNs have such an important role in anti-viral defense, it is not surprising that all viruses studied have found ways of inhibiting IFN production and or action. This application describes our plan to derive indicator cell lines and transgenic mice that will fluoresce when the IFN genes are activated. These reagents will allow virologists to study the ability of many different viruses to activate and/or suppress type I IFN production in vivo and in vitro.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SUPPLEMENT TO: A Novel approach to RSV vaccination
-
批准号:8846767
-
项目类别:
-
资助金额:$52.55万
-
财政年份:2013
-
负责人:Joan E. Durbin
-
依托单位:
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
-
批准号:8606404
-
项目类别:
-
资助金额:$118.56万
-
财政年份:2013
-
负责人:Joan E. Durbin
-
依托单位:
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
-
批准号:8704177
-
项目类别:
-
资助金额:$103.69万
-
财政年份:2013
-
负责人:Joan E. Durbin
-
依托单位:
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
-
批准号:8784187
-
项目类别:
-
资助金额:$118.59万
-
财政年份:2013
-
负责人:Joan E. Durbin
-
依托单位:
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
-
批准号:8474421
-
项目类别:
-
资助金额:$15.02万
-
财政年份:2013
-
负责人:Joan E. Durbin
-
依托单位:
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
-
批准号:9193608
-
项目类别:
-
资助金额:$119.03万
-
财政年份:2013
-
负责人:Joan E. Durbin
-
依托单位:
A Novel Approach to RSV Vaccination
-
批准号:7905533
-
项目类别:
-
资助金额:$69.81万
-
财政年份:2010
-
负责人:Joan E. Durbin
-
依托单位:
SUPPLEMENT TO: A Novel approach to RSV vaccination
-
批准号:8811246
-
项目类别:
-
资助金额:$42.93万
-
财政年份:2010
-
负责人:Joan E. Durbin
-
依托单位:
A Novel Approach to RSV Vaccination
-
批准号:8460820
-
项目类别:
-
资助金额:$20.48万
-
财政年份:2010
-
负责人:Joan E. Durbin
-
依托单位:
A Novel Approach to RSV Vaccination
-
批准号:8056668
-
项目类别:
-
资助金额:$60.01万
-
财政年份:2010
-
负责人:Joan E. Durbin
-
依托单位:
A Novel Approach to RSV Vaccination
-
批准号:8244370
-
项目类别:
-
资助金额:$60.15万
-
财政年份:2010
-
负责人:Joan E. Durbin
-
依托单位:
The Role of Type III Interferon in Innate Immunity to Respiratory Virus Infection
-
批准号:7996782
-
项目类别:
-
资助金额:$82.71万
-
财政年份:2009
-
负责人:Joan E. Durbin
-
依托单位:
The Role of Type III Interferon in Innate Immunity to Respiratory Virus Infection
-
批准号:7932906
-
项目类别:
-
资助金额:$80.99万
-
财政年份:2009
-
负责人:Joan E. Durbin
-
依托单位:
RSV Upper Airway Infection & Otitis Media
-
批准号:7000322
-
项目类别:
-
资助金额:$45.3万
-
财政年份:2004
-
负责人:Joan E. Durbin
-
依托单位:
RSV Upper Airway Infection & Otitis Media
-
批准号:6848059
-
项目类别:
-
资助金额:$45.04万
-
财政年份:2004
-
负责人:Joan E. Durbin
-
依托单位:
RSV Upper Airway Infection & Otitis Media
-
批准号:6717512
-
项目类别:
-
资助金额:$43.73万
-
财政年份:2004
-
负责人:Joan E. Durbin
-
依托单位:
INTERFERON-ALPHA/BETA IN RESPIRATORY VIRUS PATHOGENESIS
-
批准号:6287381
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2001
-
负责人:Joan E. Durbin
-
依托单位:
INTERFERON-ALPHA/BETA IN RESPIRATORY VIRUS PATHOGENESIS
-
批准号:6511246
-
项目类别:
-
资助金额:$34.31万
-
财政年份:2001
-
负责人:Joan E. Durbin
-
依托单位:
INTERFERON-ALPHA/BETA IN RESPIRATORY VIRUS PATHOGENESIS
-
批准号:6708082
-
项目类别:
-
资助金额:$34.31万
-
财政年份:2001
-
负责人:Joan E. Durbin
-
依托单位:
INTERFERON-ALPHA/BETA IN RESPIRATORY VIRUS PATHOGENESIS
-
批准号:6556202
-
项目类别:
-
资助金额:$4.9万
-
财政年份:2001
-
负责人:Joan E. Durbin
-
依托单位:
海外基金